Quinoline Antiviral: Promising SARS-CoV-2 Treatment

New hope for COVID-19 Treatment: Novel Antiviral Compound Shows Promise Table of Contents New hope for COVID-19 Treatment: Novel Antiviral Compound Shows Promise The Quest for Innovative SARS-cov-2… The post Quinoline Antiviral: Promising SARS-CoV-2 Treatment appeared first on NewsyList. Source link

Scientists stop long-COVID symptoms in mice using a new antiviral compound

A groundbreaking preclinical study reveals how targeting a viral enzyme with a new drug could prevent long-COVID complications, offering hope for millions and a powerful tool for future coronavirus threats. Study: A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID Over 77 million people globally have experienced lingering symptoms after recovering from … Read more

Does COVID-19 affect heart rate variability after recovery?

Brazilian researchers reveal that even mild cases of COVID-19 can temporarily reduce heart rate variability, with stress on the autonomic nervous system lasting up to six months—especially in older individuals. Study: Impact of COVID-19 on heart rate variability in post-COVID individuals compared to a control group. Image Credit: Swetochka / Shutterstock.com Several studies have reported that … Read more

COVID-19 Vaccines May Cut Risk of Long COVID

A new rapid review finds that full vaccination may reduce the odds of post-COVID-19 condition (PCC) by 27%, though more research is needed—especially in children and immunocompromised groups. Study: Does COVID-19 vaccination reduce the risk and duration of post COVID-19 condition? Image Credit: KomootP/Shutterstock.com A recent rapid review published by the European Center for Disease Prevention and … Read more

Scientists reveal how Epstein-Barr virus reactivation triggers MIS-C in children

Why are some children devastated by mysterious post-COVID inflammation? Scientists uncover how a ‘silent’ virus awakens – and a promising path to stop it. Study: TGFβ links EBV to multisystem inflammatory syndrome in children. Image Credit: Kateryna Kon / Shutterstock A new study published in the journal Nature reveals a potential mechanism associated with the development of … Read more

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence

Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron. Image Credit: Corona Borealis Studio/Shutterstock.com A recent Nature study investigated the consequence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) evolution, … Read more

COVID-19 speeds up artery plaque growth, raising heart disease risk

New research reveals that even mild COVID-19 can silently worsen heart health, accelerating plaque buildup and inflammation—raising the risk of future heart attacks and strokes. Study: SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events. Image Credit: Rocos / Shutterstock In a recent study published in the journal Radiology, a research … Read more

SARS-CoV-2 infection linked to rapid plaque growth in coronary arteries

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular events. The results were published today in Radiology, a journal of the Radiological Society of North America (RSNA). COVID-19, caused by SARS-CoV-2, is initially … Read more

Study uncovers distinct blood protein signature in children with Long COVID

Pediatric long COVID marked by heightened inflammation, mirroring adult cases. Proteomic profiling achieved 93% accuracy in identifying affected children, paving the way for future diagnostic advancements. Study: Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls. Image Credit: Vitalii Stock/Shutterstock.com A recent study published in Pediatric Research investigated the unique inflammatory and angiogenetic protein markers in … Read more

Azvudine beats paxlovid in reducing COVID-19 deaths

A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study: Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study. Image Credit: Cryptographer/Shutterstock.com In a recent study published in the Signal Transduction and Targeted Therapy, a … Read more